CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-16 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −1,172 | $17.77 | $21K | 9,080 |
| 2020-02-16 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion · Restricted Stock Unit Award | −3,375 | 6,750 | ||
| 2020-02-16 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion | +3,375 | 51,925 | ||
| 2020-02-16 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −1,172 | $17.77 | $21K | 50,753 |
| 2020-02-16 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −3,375 | 6,750 | ||
| 2020-02-16 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Exercise or conversion | +3,375 | 61,631 | ||
| 2020-02-16 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Shares withheld for taxes | −1,172 | $17.77 | $21K | 60,459 |
| 2020-02-16 | FRATES JAMES M SVP, Alks Inc; CFO ALKS | Exercise or conversion · Restricted Stock Unit Award | −3,375 | 6,750 | ||
| 2020-02-16 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Exercise or conversion | +2,375 | 32,777 | ||
| 2020-02-16 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Shares withheld for taxes | −825 | $17.77 | $15K | 31,952 |
| 2020-02-16 | Brown Iain Michael SVP Finance & CAO, Alks Inc. | Exercise or conversion · Restricted Stock Unit Award | −2,375 | 4,750 | ||
| 2019-12-04 | Wilson Frank Anders Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +11,200 | 11,200 | ||
| 2019-12-04 | Wilson Frank Anders Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +61,800 | 61,800 | ||
| 2019-12-04 | GAYNOR RICHARD Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +11,200 | 11,200 | ||
| 2019-12-04 | GAYNOR RICHARD Director | Grant or award · Non Qualified Stock Option (Right to Buy) | +61,800 | 61,800 | ||
| 2019-11-14 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion | +100,000 | $9.21 | $921K | 816,433 |
| 2019-11-14 | POPS RICHARD F Director and CEO, Alkermes plc | Sale | −100,000 | $19.50 | $1.9M | 716,433 |
| 2019-11-14 | POPS RICHARD F Director and CEO, Alkermes plc | Exercise or conversion · Employee Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2019-11-13 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion | +20,000 | $9.21 | $184K | 205,122 |
| 2019-11-13 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Sale | −20,000 | $19.70 | $394K | 185,122 |
Page 78 of 90 · 1,796 trades